Targeting Cardiac Fibrosis With a Vaccine Against Fibroblast Activation Protein.
作者信息
Oldham William M
机构信息
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
出版信息
Circ Res. 2025 Jan 3;136(1):41-43. doi: 10.1161/CIRCRESAHA.124.325804. Epub 2025 Jan 2.
Abstract
摘要
相似文献
1
Targeting Cardiac Fibrosis With a Vaccine Against Fibroblast Activation Protein.用抗成纤维细胞激活蛋白疫苗靶向心脏纤维化
Circ Res. 2025 Jan 3;136(1):41-43. doi: 10.1161/CIRCRESAHA.124.325804. Epub 2025 Jan 2.
2
A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts.一种针对成纤维细胞活化蛋白的疫苗通过防止肌成纤维细胞的积累改善小鼠心脏纤维化。
Circ Res. 2025 Jan 3;136(1):26-40. doi: 10.1161/CIRCRESAHA.124.325017. Epub 2024 Dec 4.
3
Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.肥胖相关性纤维化心肌病小鼠模型的特征分析，该模型重现了射血分数保留型心力衰竭的人类特征。
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H934-H949. doi: 10.1152/ajpheart.00238.2018. Epub 2018 Jul 13.
4
Single-nuclear transcriptome profiling identifies persistent fibroblast activation in hypertrophic and failing human hearts of patients with longstanding disease.单细胞转录组谱分析鉴定出患有长期疾病的肥厚和衰竭的人类心脏中持续的成纤维细胞活化。
Cardiovasc Res. 2023 Nov 25;119(15):2550-2562. doi: 10.1093/cvr/cvad140.
5
Cavin-2 promotes fibroblast-to-myofibroblast trans-differentiation and aggravates cardiac fibrosis.Cavin-2 促进成纤维细胞向肌成纤维细胞的转分化，加重心脏纤维化。
ESC Heart Fail. 2024 Feb;11(1):167-178. doi: 10.1002/ehf2.14571. Epub 2023 Oct 24.
6
Fibroblast-specific TGF-β signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice.成纤维细胞特异性转化生长因子-β信号传导介导肥胖糖尿病小鼠的心脏功能障碍、纤维化和肥大。
Cardiovasc Res. 2024 Dec 14;120(16):2047-2063. doi: 10.1093/cvr/cvae210.
7
DNMT1 deregulation of SOCS3 axis drives cardiac fibroblast activation in diabetic cardiac fibrosis.DNMT1 失调导致 SOCS3 轴驱动糖尿病性心脏纤维化中的心脏成纤维细胞激活。
J Cell Physiol. 2021 May;236(5):3481-3494. doi: 10.1002/jcp.30078. Epub 2020 Sep 28.
8
Sirtuin 3 is essential for hypertension-induced cardiac fibrosis via mediating pericyte transition.Sirtuin 3 通过介导周细胞转化对高血压诱导的心脏纤维化至关重要。
J Cell Mol Med. 2020 Jul;24(14):8057-8068. doi: 10.1111/jcmm.15437. Epub 2020 May 28.
9
Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice.利那格列汀抑制二肽基肽酶-4（DPP-4）可降低西方饮食诱导的雌性小鼠心肌TRAF3IP2表达、炎症和纤维化。
Cardiovasc Diabetol. 2017 May 5;16(1):61. doi: 10.1186/s12933-017-0544-4.
10
Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.碱性成纤维细胞生长因子通过增强 TIMP-1 表达对高血压心脏成纤维细胞的抗纤维化反应。
Cardiovasc Pathol. 2014 Mar-Apr;23(2):92-100. doi: 10.1016/j.carpath.2013.11.001. Epub 2013 Nov 14.
本文引用的文献
1
A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts.一种针对成纤维细胞活化蛋白的疫苗通过防止肌成纤维细胞的积累改善小鼠心脏纤维化。
Circ Res. 2025 Jan 3;136(1):26-40. doi: 10.1161/CIRCRESAHA.124.325017. Epub 2024 Dec 4.
2
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies.优化 CAR-T 细胞疗法治疗实体瘤：当前挑战与潜在策略。
J Hematol Oncol. 2024 Nov 5;17(1):105. doi: 10.1186/s13045-024-01625-7.
3
Current understanding and management of CAR T cell-associated toxicities.嵌合抗原受体 T 细胞相关毒性的现有认识和管理。
Nat Rev Clin Oncol. 2024 Jul;21(7):501-521. doi: 10.1038/s41571-024-00903-0. Epub 2024 May 20.
4
Characterization of a robust mouse model of heart failure with preserved ejection fraction.具有射血分数保留的心衰的稳健小鼠模型的特征描述。
Am J Physiol Heart Circ Physiol. 2023 Aug 1;325(2):H203-H231. doi: 10.1152/ajpheart.00038.2023. Epub 2023 May 19.
5
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion.CAR-T细胞疗法的准备工作：患者选择、桥接疗法和淋巴细胞清除。
Nat Rev Clin Oncol. 2022 May;19(5):342-355. doi: 10.1038/s41571-022-00607-3. Epub 2022 Mar 22.
6
Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis.成纤维细胞激活蛋白激活的抗纤维化肽递药减轻肝纤维化小鼠模型的纤维化。
Nat Commun. 2022 Mar 21;13(1):1516. doi: 10.1038/s41467-022-29186-8.
7
CAR T cells produced in vivo to treat cardiac injury.体内生成的 CAR T 细胞治疗心脏损伤。
Science. 2022 Jan 7;375(6576):91-96. doi: 10.1126/science.abm0594. Epub 2022 Jan 6.
8
Cardiac fibrosis.心肌纤维化。
Cardiovasc Res. 2021 May 25;117(6):1450-1488. doi: 10.1093/cvr/cvaa324.
9
Targeting cardiac fibrosis with engineered T cells.靶向心肌纤维化的工程化 T 细胞。
Nature. 2019 Sep;573(7774):430-433. doi: 10.1038/s41586-019-1546-z. Epub 2019 Sep 11.
10
Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosis.细胞表达成纤维细胞激活蛋白的缺失在 TGF-β 和慢性博来霉素诱导的纤维化模型中具有不同的影响。
Am J Physiol Lung Cell Mol Physiol. 2019 Aug 1;317(2):L271-L282. doi: 10.1152/ajplung.00071.2019. Epub 2019 Jun 12.
Zotero 插件